Cue Biopharma is trading 6.8% up at $29.91 as shares rebound from yesterday’s pullback and participate in a broader risk-on move in U.S. equities.
- The stock appears to be moving in line with renewed strength in growth and biotech names rather than on any company-specific catalyst.
- The upward move coincides with broader market gains, as the Nasdaq and S&P 500 both rose more than 1% during the session.